ArticleCellular signalling2007
Palmitoylation of the TPbeta isoform of the human thromboxane A2 receptor. Modulation of G protein: effector coupling and modes of receptor internalization.
Article in Cellular signalling, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It has been retracted, and should not be counted. Cited by 14 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
14 citing papers in PubMed, 28 citations in OpenAlex.
- The Role and Regulation of Thromboxane AMolecules (Basel, Switzerland) · 2022Review
- Emerging roles of protein palmitoylation and its modifying enzymes in cancer cell signal transduction and cancer therapy.International journal of biological sciences · 2022Review
- Post-Translational Modifications of G Protein-Coupled Receptors Control Cellular Signaling Dynamics in Space and Time.Pharmacological reviews · 2021Review
- Effects of Post-translational Modifications on Membrane Localization and Signaling of Prostanoid GPCR-G Protein Complexes and the Role of Hypoxia.The Journal of membrane biology · 2019Review
- DifferentialThe Journal of biological chemistry · 2019Article
- Protein Lipidation: Occurrence, Mechanisms, Biological Functions, and Enabling Technologies.Chemical reviews · 2018Article
- Expression of the TPα and TPβ isoforms of the thromboxane prostanoid receptor (TP) in prostate cancer: clinical significance and diagnostic potential.Oncotarget · 2016Article
- Palmitoylation of protease-activated receptor-1 regulates adaptor protein complex-2 and -3 interaction with tyrosine-based motifs and endocytic sorting.The Journal of biological chemistry · 2013Article
- Heterodimerization with the prostacyclin receptor triggers thromboxane receptor relocation to lipid rafts.Arteriosclerosis, thrombosis, and vascular biology · 2013Article
- Molecular dynamics simulations reveal specific interactions of post-translational palmitoyl modifications with rhodopsin in membranes.Journal of the American Chemical Society · 2012Article
- Differential regulation of two palmitoylation sites in the cytoplasmic tail of the beta1-adrenergic receptor.The Journal of biological chemistry · 2011Article
- Interaction of the human prostacyclin receptor with Rab11: characterization of a novel Rab11 binding domain within alpha-helix 8 that is regulated by palmitoylation.The Journal of biological chemistry · 2010Article
- Thromboxane and the thromboxane receptor in cardiovascular disease.Clinical lipidology · 2010Article
- Palmitoylation of interferon-alpha (IFN-alpha) receptor subunit IFNAR1 is required for the activation of Stat1 and Stat2 by IFN-alpha.The Journal of biological chemistry · 2009Article
Corrections and comments
- Correction · 2017-07-25Error in Image ·
- Correction · 2015-12-29Error in Image ·
- Erratum issued
- Erratum issued
Authors and funding
2 authors at 1 institution in 1 country.
Funding
Abstract
Palmitoylation is a prevalent feature amongst G protein-coupled receptors. In this study we sought to establish whether the TPalpha and TPbeta isoforms of the human prostanoid thromboxane (TX) A2 receptor (TP) are palmitoylated and to assess the functional consequences thereof. Consistent with the presence of three cysteines within its unique carboxyl-terminal domain, metabolic labelling and site-directed mutagenesis confirmed that TPbeta is palmitoylated at Cys347 and, to a lesser extent, at Cys373,377 whereas TPalpha is not palmitoylated. Impairment of palmitoylation did not affect TPbeta expression or its ligand affinity. Conversely, agonist-induced [Ca2+]i mobilization by TPbetaC347S and the non-palmitoylated TPbetaC347,373,377S, but not by TPbetaC373S or TPbetaC373,377S, was significantly reduced relative to the wild type TPbeta suggesting that palmitoylation at Cys347 is specifically required for efficient Gq/phospholipase Cbeta effector coupling. Furthermore, palmitoylation at Cys373,377 is critical for TPbeta internalization with TPbetaC373S, TPbetaC373,377S and TPbetaC347,373,377S failing to undergo either agonist-induced or temperature-dependent tonic internalization. On the other hand, whilst TPbetaC347S underwent reduced agonist-induced internalization, it underwent tonic internalization to a similar extent as TPbeta. The deficiency in agonist-induced internalization by TPbetaC347S, but not by TPbetaC373,377 nor TPbeta(C347,373,377S), was overcome by over-expression of either beta-arrestin1 or beta-arrestin2. Taken together, data herein suggest that whilst palmitoylation of TPbeta at Cys373,377 is critical for both agonist- and tonic-induced internalization, palmitoylation at Cys347 has a role in determining which pathway is followed, be it by the beta-arrestin-dependent agonist-induced pathway or by the beta-arrestin-independent tonic internalization pathway.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.